Lonza

Health Care Technology / Biotechnology
LONN.SW
CHF 464 0.04
Share price
$ 39 bn
Market Cap
$ 40 bn
Enterprise Value

Carbon footprint

12 Ton
GHG emissions per $ 1 mln investment
0.35x the weighted average for S&P 500
FY2021
How is this calculated?
-65%
YOY change in GHG emissions
Stronger than the -11% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

but has a science based goal that does not target absolute reductions but is still aligned with Paris Agreement according to SBTi

GHG emissions and Carbon intensity

Lonza's GHG emissions (market-based) (Kt of CO2e)
Lonza's Carbon intensity (Tons per 1 USDm)

Lonza's carbon footprint

Lonza reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 470 Kt (-858 /-64.6% y-o-y). Also positively, carbon intensity declined to 79 t (-191 /-70.7% y-o-y).

Lonza reported Scope 3 emissions for the the twelve months ending31 December 2021 at 2,452

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Lonza also has a science-based goal that, however, does not appear to explicitly target a company-wide reduction in emissions in absolute terms. Lonza commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2021 base year*. Lonza also commits that 79% of its suppliers by emissions covering purchased goods and services, capital goods and upstream transportation and distribution, will have science-based targets by 2028. *The target boundary includes biogenic land-related emissions and removals from bioenergy feedstocks.

Company environmental metrics

Show more...